ArticleCHEST pulmonary2025
Lymphangioleiomyomatosis Patient Research Priorities Survey (LAM-PREP): Developing a Patient-Centered Research Agenda.
Article in CHEST pulmonary, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Educational attainment of individuals with lymphangioleiomyomatosis is a determinant of timely diagnosis and treatment uptake.Orphanet journal of rare diseases · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Engaging patients in developing research agendas is recognized as critical in advancing scientific discovery and improving clinical care. There is a scarcity of such studies for respiratory diseases, particularly rare conditions like lymphangioleiomyomatosis (LAM). Research Question: Can a comprehensive study inform and guide future LAM research for the benefit of patients, researchers, and clinical providers? Study Design and Methods: We used a mixed-methods analysis consisting of focus groups of patients and caregivers. Participant responses were thematically analyzed and grouped into categories and subcategories using qualitative content analysis to generate a list of health needs, quality of life issues, and research areas. A survey to rank the priorities was then developed and administered electronically to patients with LAM, caregivers, scientists, and clinicians. Results: The LAM Patient Research Priorities Survey (LAM-PREP) revealed a list of priorities centered on health, quality of life, and research needs. Areas of agreement among all respondents were prioritizing awareness of LAM among health care providers, access to comprehensive care, understanding and interpreting symptoms, mental health, managing supplemental oxygen, finding new treatments and a cure, and studying the role of hormones in LAM disease and treatment. Clinicians prioritized needs relating to travel, sexual and women's health, and childbearing and family planning. Patients prioritized questions regarding LAM and sleep quality, safe exercise, and the impact of diet. Both scientists and clinicians noted a priority in studying disease onset and progression. Interpretation: LAM-PREP integrated diverse perspectives on LAM research and clinical priorities from LAM community stakeholders. These findings should serve as a roadmap for developing and implementing projects and interventions to improve the health outcomes of women living with LAM. Importantly, LAM-PREP can serve as a model for developing patient-focused research agendas for other rare diseases, particularly those affecting women.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.